Each year, about 400,000 people in the U.S. are newly diagnosed with carotid artery disease, a narrowing of the arteries in the neck that supply blood to the brain. This buildup of plaque is responsible for roughly one-third of all strokes — a leading cause of death nationwide.
A long-awaited study may reshape how doctors treat the condition.
The CREST-2 clinical trial, more than a decade in the making, found that placing a stent in the carotid artery significantly reduced stroke risk in certain patients with asymptomatic but high-grade carotid stenosis, compared to medication alone.
CREST-2 initially was designed to test whether modern medications, such as statins, could be so effective that invasive procedures like surgery and stent placement might no longer be necessary, explained Amish Mehta, director of noninvasive cardiology and subchief of cardiology at AHN Jefferson Hospital. Its two major findings were that stenting provides a meaningful benefit and surgery is no longer automatically the first choice, said Mehta, who was not involved in the study.
For patients treated with intensive medical therapy alone, the risk of stroke or death was 6%, compared with 2.8% among those who also received a carotid stent. In contrast, the trial found no statistically significant benefit for the traditional surgical approach, called carotid endarterectomy, over medication and medical therapy alone.
The findings, published in the New England Journal of Medicine in November, are expected to shift national guidelines, possibly toward broader use of stenting and more individualized surgical decision-making.
Why doctors are paying close attention
Thomas Simone, a vascular surgeon at St. Clair Health, said the new publication illuminates the role and benefit of stents — especially because earlier studies, including the original CREST trial, had indicated that carotid endarterectomy surgery appeared to be the better option in all cases.
That procedure is performed by making a small incision in a patient’s neck and opening the carotid artery. The plaque (or fatty deposits) is scraped out and the artery is stitched closed.
Simone noted that CREST-1’s subgroup analyses later revealed some advantages to surgery compared to stenting in women, those over 80 years old and in symptomatic patients, but pointed out that CREST-2 focused solely on patients without symptoms.
The stent procedure serves as a preventive option for asymptomatic patients, “so that they do not eventually experience a stroke,” said Simone, who was not involved with the current study.
“These are tricky patients. They don't have any problems yet.”
Simone said that in this asymptomatic group, the study findings indicate that there was a benefit to preventive stenting, while surgery yielded only slightly better results than medical therapy alone. Medical therapies include lifestyle changes like smoking cessation and losing weight, taking a daily prophylactic aspirin, and prescription medication to control diabetes, weight, cholesterol and high blood pressure.
What is carotid artery disease?
For many people, carotid artery disease is a condition they’d never heard of — until they’re diagnosed with it by chance, Mehta said.
The disease is a form of atherosclerosis, the buildup of plaque inside the arteries, which falls under the broader category of arteriosclerosis, which many in the past referred to as “hardening of the arteries.”
Atherosclerosis can affect almost any artery in the body, including those in the heart, brain, arms, legs, pelvis and kidneys.
Most people with the condition never experience symptoms.
“It is something that is usually found incidentally,” Mehta said, often while a patient is receiving imaging for neck pain, thyroid issues or other unrelated concerns.
Simone agreed that incidental detection is common, and that some patients are labeled asymptomatic, even though the initial imaging was prompted by “a visual disturbance in one eye,” which can be a symptom of both carotid artery disease or an impending stroke.
Why CREST-2 is a big deal
Before stents were introduced, carotid endarterectomy was the gold standard. It became widely adopted after a 1995 study showed it was superior to taking an aspirin alone.
Stenting emerged in the early 2000s, leading to the original CREST trial, which found surgery and stenting had similar outcomes in certain patients — but that stenting carried a slightly higher risk of stroke.
Mehta noted that medical therapy has since improved dramatically: In addition to aspirin, doctors often also prescribe statins and “we’re also much more aggressive and careful about a person's blood pressure, sugar… and then if they're smokers, we ask them to quit smoking.”
The CREST-2 found no statistical advantage for surgery over medical therapy, counter to decades of practice.
Mehta said the results reinforce what he’s witnessed among his peers in recent years: many physicians are being more conservative — waiting a bit longer — before recommending surgery to treat the condition.
Still, he emphasized that exceptions exist: “There are certainly exceptions to the rule where surgery may, in fact, be better,” such as if a patient is younger.
For Mehta, the CREST-2 findings underscore that medical therapy can be beneficial to all.
Simone noted that a more detailed analysis of patient subgroups — divided by age, sex, location of plaque and more — is still needed before narrowing down exactly who benefits most.
Stenting versus surgery
Carotid stenting is minimally invasive. Doctors guide a catheter from the groin to the neck — called transfemoral catheterization — expand the narrowed area, and place a permanent metal scaffold, or stent.
Before placing the stent, a small filter, or net, is placed upstream from the stent location to catch any plaque debris that may break loose during the procedure. After the stent is in place, the catheter and filter are both removed, Mehta said.

Surgery is more involved. “They open up the carotid … literally kind of scrape or carve away the plaque,” he said.
A missing piece: the rise of T-CAR
One major modern option wasn’t included in CREST-2 at all: transcarotid artery revascularization, or T-CAR.
Simone emphasized this gap, calling it “conspicuously absent” because T-CAR was not around when the CREST-2 trial kicked off.
T-CAR is a hybrid approach — still a stent, but placed directly through a small neck incision — eliminating the need to insert the catheter via the groin — with blood flow temporarily reversed to capture plaque debris, Simone explained.
Registry data — not randomized trials — suggest T-CAR has stroke rates “certainly equivalent to carotid endarterectomy” and better than transfemoral stenting. It also avoids a surgical risk of “cranial nerve injury,” which occurs in about 2.5% of endarterectomy cases but “falls to close to zero” with T-CAR.
Simone said that in his practice, “I rarely see indications for transfemoral stenting,” because T-CAR is often a safer alternative when a stent is needed.
Who might benefit from a stent
Stenting isn’t right for everyone; those who tend to benefit the most from a stent are “younger people who don't have as much calcium build up” and those with lesions located higher in the neck, Mehta said.
Simone added that stenting candidates must have met the trial’s strict criteria: “over 70%” arterial narrowing and a favorable anatomy. But he cautioned that the benefit, while real, is modest — making the shared decision-making conversation between doctors and patients crucial.
The most serious complication shared by both procedures is stroke. If the plaque breaks off during stenting, it can cause a blockage despite the protective filter, Mehta said. Surgery carries a risk of heart attack because patients also often have plaque in their coronary arteries.
Simone noted additional nuances from CREST-1 subgroup data: women, symptomatic patients and adults over age 80 faced higher stroke risk with transfemoral stents.
Medical therapy still matters most
Regardless of whether a patient receives a stent, Mehta stressed the importance of medication and lifestyle changes.
“Lower is better: lower blood pressure, lower cholesterol, lower blood sugar, lower weight.”
Additionally, a baby aspirin per day — a commonly prescribed therapy since the 1970s and ’80s — is still considered to be helpful.
Another important step for anyone is recognizing — and, especially, not ignoring — stroke symptoms, both doctors agreed.
Seek medical attention immediately if you experience sudden vision loss, weakness, numbness, tingling or slurred speech. Getting care as soon as possible is critical because there are treatments available today that can make a big difference, Mehta said.






Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.